Support for and potential impacts of key Smokefree 2025 strategies among Māori who smoke.


Journal

The New Zealand medical journal
ISSN: 1175-8716
Titre abrégé: N Z Med J
Pays: New Zealand
ID NLM: 0401067

Informations de publication

Date de publication:
21 Jul 2023
Historique:
medline: 31 7 2023
pubmed: 28 7 2023
entrez: 28 7 2023
Statut: epublish

Résumé

The recently passed Smokefree Environments and Regulated Products (Smoked Tobacco) Amendment Act has the potential to profoundly reduce smoking prevalence and related health inequities experienced among Māori. This study examined support for, and potential impacts of, key measures included within the legislation. Data came from Wave 1 (2017-2019) of the Te Ara Auahi Kore longitudinal study, which was conducted in partnership with five primary health organisations serving Māori communities. Participants were 701 Māori who smoked. Analysis included both descriptive analysis and logistic regression. More Māori participants supported than did not support the Smokefree 2025 (SF2025) goal of reducing smoking prevalence to below 5%, and the key associated measures. Support was greatest for mandating very low nicotine cigarettes (VLNCs). Participants also believed VLNCs would prompt high rates of quitting. Participants who had made more quit attempts or reported less control over their life were more likely to support VLNCs. There was support for the SF2025 goal and for key measures that could achieve it. In particular, VLNCs may have significant potential to reduce smoking prevalence among Māori. As part of developing and implementing these measures it will be important to engage with Māori who smoke and their communities.

Identifiants

pubmed: 37501244

Substances chimiques

Tobacco Smoke Pollution 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

49-61

Subventions

Organisme : For this study Geoff Fong and Anne Quah were supported by the Canadian Institutes of Health Research (FDN-148477). Geoff Fong also received support from the Ontario Institute of Cancer Research.

Informations de copyright

© PMA.

Déclaration de conflit d'intérêts

Geoffrey T Fong has served as an expert witness or a consultant for governments defending their country’s policies or regulations in litigation. All other authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Auteurs

Andrew Waa (A)

Te Rōpū Rangahau Hauora a Eru Pōmare, Department of Public Health University of Otago, New Zealand.

Ellie Johnson (E)

Department of Public Health, University of Otago, New Zealand.

James Stanley (J)

Department of Public, Health University of Otago, Wellington, New Zealand.

Bridget Robson (B)

Te Rōpū Rangahau Hauora a Eru Pōmare, University of Otago, Wellington, New Zealand.

Anania Kerehoma Cook (AK)

Researcher Independent, New Zealand.

Erana Peita (E)

Whānau Engagement & Innovation Partner, Mahitahi Hauora, New Zealand.

Anne Ck Quah (AC)

Department of Psychology, University of Waterloo, Canada.

Geoffrey T Fong (GT)

Department of Psychology, University of Waterloo, Canada.

Richard Edwards (R)

Public Health, University of Otago Wellington, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH